EU Agency Warns Of GSK Epilepsy Drug's Vision Risks
The European Medicines Agency recommended Friday that patients take a GlaxoSmithKline PLC epilepsy drug only as a last resort because of concerns it can impair their vision and discolor their skin,...To view the full article, register now.
Already a subscriber? Click here to view full article